Phillips, Anna E.
Ower, Alison K.
Mekete, Kalkidan
Liyew, Ewnetu Firdawek
Maddren, Rosie
Belay, Habtamu
Chernet, Melkie
Anjulo, Ufaysa
Mengistu, Birhan
Salasibew, Mihretab
Tasew, Geremew
Anderson, Roy
Funding for this research was provided by:
Children's Investment Fund Foundation
Article History
Received: 16 January 2022
Accepted: 3 September 2022
First Online: 4 November 2022
Declarations
:
: Ethical approval has been obtained from the Scientific and Ethical Review Office of the Ethiopian Public Health Institute. Permission letters have been secured from Regional and Zonal Health Offices and Educational Bureaus. They have been shared with the district Health Office and community administrators and school directors. Verbal informed consent will be obtained from study participants after thorough information has been provided in the local language on the aim and procedures of the study and documented electronically through the data collection form. Assent will be obtained from school-aged children. Name and other identifiers will be excluded from the analysis for the sake of confidentiality. Moreover, it is the right of the participant to refuse to give information and drop out of the study at any time. Those found to be infected with STH or schistosomiasis will be given a treatment of either PZQ 40 mg/kg or ALB, respectively. School head teachers and members of school management committees provided written consent in loco parentis. A meeting with parents and school administrators at participating schools was also conducted at baseline to explain the procedures, benefits of the programme, and benefits and risks to participation. Pupils provided oral assent in the trial before providing a stool sample collection.
: Not applicable.
: The authors declare that they have no competing interests.